Skip to main content
. 2020 Jan 20;236(3):199–207. doi: 10.1159/000504536

Fig. 3.

Fig. 3

Microbiological success rates at visit 2 (day 3–4 of treatment) in ozenoxacin- and vehicle-treated paediatric patients stratified by age group. Microbiological success was defined as the absence of original pathogen(s) in culture of the baseline specimen with/without the presence of new micro-organisms. *** p < 0.0001.